Eva M. Lonn
Department of Medicine
McMaster University
Hamilton
Ontario
Canada
Name/email consistency: high
- Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone). Lonn, E.M., Gerstein, H.C., Sheridan, P., Smith, S., Diaz, R., Mohan, V., Bosch, J., Yusuf, S., Dagenais, G.R. J. Am. Coll. Cardiol. (2009)
- Homocysteine in the prevention of ischemic heart disease, stroke and venous thromboembolism: therapeutic target or just another distraction? Lonn, E. Curr. Opin. Hematol. (2007)
- Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trial. Lonn, E., Held, C., Arnold, J.M., Probstfield, J., McQueen, M., Micks, M., Pogue, J., Sheridan, P., Bosch, J., Genest, J., Yusuf, S. Can. J. Cardiol (2006)
- Homocysteine lowering with folic acid and B vitamins in vascular disease. Lonn, E., Yusuf, S., Arnold, M.J., Sheridan, P., Pogue, J., Micks, M., McQueen, M.J., Probstfield, J., Fodor, G., Held, C., Genest, J. N. Engl. J. Med. (2006)
- Drug therapies in the secondary prevention of cardiovascular diseases: Successes, shortcomings and future directions. Lonn, E., Grewal, J. Curr. Vasc. Pharmacol (2006)
- Effects of ramipril on left ventricular mass and function in cardiovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction: a substudy of the Heart Outcomes Prevention Evaluation (HOPE) Trial. Lonn, E., Shaikholeslami, R., Yi, Q., Bosch, J., Sullivan, B., Tanser, P., Magi, A., Yusuf, S. J. Am. Coll. Cardiol. (2004)
- The clinical relevance of pharmacological blood pressure lowering mechanisms. Lonn, E. Can. J. Cardiol (2004)
- Relationship of electrocardiographic left ventricular hypertrophy to mortality and cardiovascular morbidity in high-risk patients. Lonn, E., Mathew, J., Pogue, J., Johnstone, D., Danisa, K., Bosch, J., Baird, M., Dagenais, G., Sleight, P., Yusuf, S. Eur. J. Cardiovasc. Prev. Rehabil (2003)
- Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in atherosclerosis. Lonn, E. Curr. Atheroscler. Rep (2002)
- Effect of long-term therapy with ramipril in high-risk women. Lonn, E., Roccaforte, R., Yi, Q., Dagenais, G., Sleight, P., Bosch, J., Suhan, P., Micks, M., Probstfield, J., Bernstein, V., Yusuf, S. J. Am. Coll. Cardiol. (2002)
- Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy. Lonn, E., Yusuf, S., Hoogwerf, B., Pogue, J., Yi, Q., Zinman, B., Bosch, J., Dagenais, G., Mann, J.F., Gerstein, H.C. Diabetes. Care (2002)
- Dose response of ACE inhibitors: implications of the SECURE trial. Lonn, E. Curr. Control. Trials. Cardiovasc. Med (2001)